Back to Search Start Over

Deep grey matter volume loss drives disability worsening in multiple sclerosis

Authors :
Arman Eshaghi
Ferran Prados
Wallace Brownlee
Daniel R. Altmann
Carmen Tur
M. Jorge Cardoso
Floriana De Angelis
Steven H. van de Pavert
Niamh Cawley
Nicola De Stefano
M. Laura Stromillo
Marco Battaglini
Serena Ruggieri
Claudio Gasperini
Massimo Filippi
Maria A. Rocca
Alex Rovira
Jaume Sastre-Garriga
Hugo Vrenken
Cyra E Leurs
Joep Killestein
Lukas Pirpamer
Christian Enzinger
Sebastien Ourselin
Claudia A.M. Gandini Wheeler-Kingshott
Declan Chard
Alan J. Thompson
Daniel C. Alexander
Frederik Barkhof
Olga Ciccarelli
Publication Year :
2017
Publisher :
Cold Spring Harbor Laboratory, 2017.

Abstract

ObjectiveGrey matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigated whether there is a spatiotemporal pattern of GM atrophy that is associated with faster disability accumulation in MS.MethodsWe analysed 3,604 brain high-resolution T1-weighted MRI scans from 1,417 participants: 1,214 MS patients (253 clinically-isolated syndrome[CIS], 708 relapsingremitting[RRMS], 128 secondary-progressive[SPMS], 125 primary-progressive[PPMS]), over an average follow-up of 2.41 years (standard deviation[SD]=1.97), and 203 healthy controls (HCs) [average follow-up=1.83 year, SD=1.77], attending 7 European centres. Disability was assessed with the Expanded-Disability Status Scale (EDSS). We obtained volumes of the deep GM (DGM), temporal, frontal, parietal, occipital and cerebellar GM, brainstem and cerebral white matter. Hierarchical mixed-models assessed annual percentage rate of regional tissue loss and identified regional volumes associated with time-to-EDSS progression.ResultsSPMS showed the lowest baseline volumes of cortical GM and DGM. Of all baseline regional volumes, only that of the DGM predicted time-to-EDSS progression (hazard ratio=0.73, 95% CIs 0.65, 0.82; pppInterpretationThis large multi-centre and longitudinal study shows that DGM volume loss drives disability accumulation in MS, and that temporal cortical GM shows accelerated atrophy in SPMS than RRMS. The difference in regional GM atrophy development between phenotypes needs to be taken into account when evaluating treatment effect of therapeutic interventions.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....588f3c649948f782bf151c7f7e6973e3
Full Text :
https://doi.org/10.1101/182006